Owens & Minor price target lowered to $9.60 from $12 at BofA

BofA lowered the firm’s price target on Owens & Minor to $9.60 from $12 and keeps an Underperform rating on the shares. The company reported a mixed quarter with solid Patient Direct growth offsetting weakness in Products and Healthcare Services, the analyst tells investors in a research note. The firm reduced estimates post the earnings print.